Fangjun Zhou

3.7k citations

56 papers · 2.8k indexed · 2 hit papers · h-index 24

Impact in

Hepatology top 1%
- Hepatitis Viruses Studies and Epidemiology
- Hepatitis C virus research
Health top 0.5%
- Vaccine Coverage and Hesitancy

Papers in ⓘ

Health 35
- Vaccine Coverage and Hesitancy 35
Epidemiology 34
- Influenza Virus Research Studies 13
- Hepatitis B Virus Studies 8
- Pneumonia and Respiratory Infections 6
- Herpesvirus Infections and Treatments 6

Co-authors: Abigail Shefer (8 shared papers)Stephen C. Hadler (1 shared paper)Eric E. Mast (1 shared paper)Susan T. Goldstein (1 shared paper)Beth P. Bell (1 shared paper)Harold S. Margolis (1 shared paper)Kong Yuan (4 shared papers)J. Pekka Nuorti (1 shared paper)
Journals: Vaccine (12 papers)PEDIATRICS (6 papers)Journal of Adolescent Health (3 papers)The Journal of Infectious Diseases (3 papers)Health Affairs (2 papers)
Partner nations: United States Australia South Africa

In The Last Decade

Fangjun Zhou

54 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program — United States, 1994–2023 2024 · 36 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 MMWR Morbidity and Mortality Weekly Report
2005 International Journal of Epidemiology

Peers

Countries citing papers authored by Fangjun Zhou

Since Specialization

Citations

This map shows the geographic impact of Fangjun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangjun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangjun Zhou more than expected).

Fields of papers citing papers by Fangjun Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangjun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangjun Zhou. The network helps show where Fangjun Zhou may publish in the future.

Co-authors

The 25 scholars most cited alongside Fangjun Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fangjun Zhou Line = papers co-authored together Fangjun Zhou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A mathematical model to estimate global hepatitis B disease burden and vaccination impact International Journal of Epidemiology ·Susan T. Goldstein, Fangjun Zhou, Stephen C. Hadler, Beth P. Bell, Eric E. Mast, Harold S. Margolis Hit paper breakdown →	2005	538
2	Trends in Acute Otitis Media-Related Health Care Utilization by Privately Insured Young Children in the United States, 1997–2004 PEDIATRICS ·Fangjun Zhou, Abigail Shefer, Kong Yuan, J. Pekka Nuorti	2008	231
3	Economic Evaluation of the Routine Childhood Immunization Program in the United States, 2009 PEDIATRICS ·Fangjun Zhou, Abigail Shefer, Jay D. Wenger, Mark L. Messonnier, Li Yan Wang, Adriana Lopez, Matthew R. Moore, Trudy V. Murphy, Margaret M. Cortese, Lance E. Rodewald	2014	193
4	Benefits from immunization during the vaccines for children program era - United States, 1994-2013. PubMed ·Cynthia G. Whitney, Fangjun Zhou, James A. Singleton, Anne Schuchat	2014	183
5	Impact of Varicella Vaccination on Health Care Utilization JAMA ·Fangjun Zhou	2005	181
6	Herpes Zoster Incidence Among Insured Persons in the United States, 1993–2006: Evaluation of Impact of Varicella Vaccination Clinical Infectious Diseases ·Jessica Leung, Rafael Harpaz, Noelle‐Angelique Molinari, Aisha O. Jumaan, Fangjun Zhou	2011	169
7	Rotavirus Vaccine and Health Care Utilization for Diarrhea in U.S. Children New England Journal of Medicine ·Jennifer Cortes, Aaron T. Curns, Jacqueline E. Tate, Margaret M. Cortese, Manish Patel, Fangjun Zhou, Umesh D. Parashar	2011	130
8	Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule in the United States, 2001 Archives of Pediatrics and Adolescent Medicine ·Fangjun Zhou, Jeanne M. Santoli, Mark L. Messonnier, Hussain Yusuf, Abigail Shefer, Susan Y. Chu, Lance E. Rodewald, Rafael Harpaz	2005	125
9	Health Care Utilization for Pneumonia in Young Children After Routine Pneumococcal Conjugate Vaccine Use in the United States Archives of Pediatrics and Adolescent Medicine ·Fangjun Zhou	2007	106
10	Rotavirus Vaccines and Health Care Utilization for Diarrhea in the United States (2007–2011) PEDIATRICS ·Eyal Leshem, Rebecca E. Moritz, Aaron T. Curns, Fangjun Zhou, Jacqueline E. Tate, Benjamin A. Lopman, Umesh D. Parashar	2014	96
11	An Economic Analysis of the Current Universal 2-dose measles-mumps-rubella Vaccination Program in the United States The Journal of Infectious Diseases ·Fangjun Zhou, Susan E. Reef, Mehran S. Massoudi, Hussain Yusuf, Barbara H. Bardenheier, Laura Zimmerman	2004	73
12	An Economic Analysis of the Universal Varicella Vaccination Program in the United States The Journal of Infectious Diseases ·Fangjun Zhou, Ismael R. Ortega‐Sanchez, Dalya Güriş, Abigail Shefer, Tracy A. Lieu, Jane F. Seward	2008	65
13	Impact of UniversalHaemophilus influenzaeType b Vaccination Starting at 2 Months of Age in the United States: An Economic Analysis PEDIATRICS ·Fangjun Zhou, Kristine M. Bisgard, Hussain Yusuf, Robert Deuson, Sue K. Bath, Trudy V. Murphy	2002	65
14	Patient Characteristics and Costs Associated With COVID-19–Related Medical Care Among Medicare Fee-for-Service Beneficiaries Annals of Internal Medicine ·Yuping Tsai, Tara M. Vogt, Fangjun Zhou	2021	49
15	A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations Annals of Internal Medicine ·Lisa A. Prosser, Rafael Harpaz, Angela M. Rose, Acham Gebremariam, Angela Guo, Ismael R. Ortega‐Sanchez, Fangjun Zhou, Kathleen Dooling	2019	46
16	Cost-Effectiveness of Using 2 vs 3 Primary Doses of 13-Valent Pneumococcal Conjugate Vaccine PEDIATRICS ·Charles Stoecker, Lee M. Hampton, Ruth Link‐Gelles, Mark L. Messonnier, Fangjun Zhou, Matthew R. Moore	2013	41
17	Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes Diabetes Care ·Thomas J. Hoerger, Sarah Schillie, John S. Wittenborn, Christina Bradley, Fangjun Zhou, Kathy K. Byrd, Trudy V. Murphy	2012	39
18	Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program — United States, 1994–2023 MMWR Morbidity and Mortality Weekly Report ·Fangjun Zhou, Tara C. Jatlaoui, Andrew J. Leidner, Rosalind J. Carter, Xiaoyu Dong, Jeanne M. Santoli, Shannon Stokley, Demetre Daskalakis, Georgina Peacock Hit paper breakdown →	2024	36
19	Trends and Characteristics of Preventive Care Visits among Commercially Insured Adolescents, 2003-2010 The Journal of Pediatrics ·Yuping Tsai, Fangjun Zhou, Pascale Wortley, Abigail Shefer, Shannon Stokley	2013	33
20	Impact of hepatitis A vaccination on health care utilization in the United States, 1996–2004 Vaccine ·Fangjun Zhou, Abigail Shefer, Cindy M. Weinbaum, Mary M. McCauley, Kong Yuan	2007	31

About Fangjun Zhou

Fangjun Zhou is a scholar working on Health, Epidemiology, Hepatology, Infectious Diseases and Microbiology, having authored 56 papers that have together received 2.8k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (35 papers), Hepatitis Viruses Studies and Epidemiology (18 papers), Influenza Virus Research Studies (13 papers), Viral gastroenteritis research and epidemiology (10 papers), Hepatitis B Virus Studies (8 papers), Bacterial Infections and Vaccines (7 papers), Pneumonia and Respiratory Infections (6 papers) and Herpesvirus Infections and Treatments (6 papers). The work is most often cited by research in Hepatology (822 citations), Health (814 citations), Epidemiology (1.9k citations), Microbiology (306 citations) and Infectious Diseases (599 citations). Fangjun Zhou has collaborated with scholars based in United States, Australia and South Africa. Frequent co-authors include Abigail Shefer, Stephen C. Hadler, Eric E. Mast, Susan T. Goldstein, Beth P. Bell, Harold S. Margolis, Kong Yuan, J. Pekka Nuorti, Rafael Harpaz and Mark L. Messonnier. Their work appears in journals such as Vaccine, PEDIATRICS, Journal of Adolescent Health, The Journal of Infectious Diseases and Health Affairs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact